ELF SANOFI, BAYER AG ANNOUNCE INTEREST IN BIDDING FOR STERLING OTC COMPONENTS
This article was originally published in The Tan Sheet
Executive Summary
ELF SANOFI, BAYER AG ANNOUNCE INTEREST IN BIDDING FOR STERLING OTC COMPONENTS in statements released shortly after Eastman Kodak's May 3 announcement that it is seeking buyers for its Sterling Winthrop prescription and OTC businesses. Sanofi is interested in purchasing Sterling's European prescription and OTC businesses, which it already manages under a 1991 alliance with Sterling. Bayer emphasized its interest in expanding its U.S. OTC business.